Bullish Moving Averages
16
Bearish Moving Averages
0
Back Stocks profile
Stock analysis tool for investors
Performance
Today’s low
109.60Today’s High
115.7052W low
74.1052W High
136.40Open Price
115.70Prev. Close
89.2700Volume
8393.00Value
931203.35Fundamentals
Market Cap Cr
55.90
Price to Earnings
-19.90
Price to Book Value
0.90
Dividend Yield
0.00
PE to Growth
0.00
Op Revenue TTM Cr
88.25
Net Profit TTM Cr
-2.81
Cash From Operating Activity Cr
4.22
Return on Equity %
-4.70
EMA & SMA
DELIVERY AND VOLUME
DAILY AVG. DELIVERY VOLUME %
03 Jul, 2024
83.8
Week
76.1
Month
75.2
LEGEND
Positive Indicator
Neutral Indicator
Negative Indicator
RESISTANCE AND SUPPORT
112.07
PIVOT
First Resistance
114.58
Second Resistance
118.22
Third Resistance
120.73
First Support
108.43
Second Support
105.92
Third Support
102.28
Relative Strength Index
65.12
Money Flow Index
70.37
MACD
2.31
MACD Signal
0.51
Average True Range
6.5
Average Directional Index
22.26
Rate of Change (21)
19.58
Rate of Change (125)
9.2
Commodity Channel Index
197.1
Williams %R
-20.5
BETA
1 Month
0.49
3 Month
1.18
1 Year
0.63
3 Year
0.38
PRICE CHANGE ANALYSIS
↑ 13.04%
1 Week
Low
High
96
115.7
↑ 18.6%
1 Month
Low
High
85.5
115.7
↑ 20.01%
3 Months
Low
High
85.5
136.4
↑ 9.26%
6 Months
Low
High
74.1
136.4
↑ 21.19%
1 Year
Low
High
74.1
136.4
| Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Graph |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Qtr Revenue cr | 7.55 | 8.56 | 7.34 | 9.80 | 6.73 | 8.23 | 7.07 | 7.74 | 6.84 | 9.62 | 7.57 | |
| Operating Expenses Qtr | 7.76 | 7.85 | 8.12 | 8.72 | 6.98 | 7.55 | 7.25 | 6.99 | 6.62 | 8.00 | 7.64 | |
| Operating Profit Qtr | -0.41 | -1.01 | -0.85 | 0.99 | -0.51 | -1.02 | -0.21 | 0.64 | 0.06 | 0.47 | -0.61 | |
| EBIDT Qtr Cr | -0.21 | 0.71 | -0.78 | 1.08 | -0.25 | 0.68 | -0.18 | 0.74 | 0.21 | 1.62 | -0.08 | |
| Depreciation Qtr | 0.64 | 0.66 | 0.65 | 0.64 | 1.55 | 0.32 | 0.32 | 0.35 | 0.62 | 0.62 | 0.64 | |
| Net Profit Qtr | -1.37 | -0.31 | -1.81 | 0.08 | -2.12 | 0.05 | -0.89 | 0.07 | -0.74 | 0.68 | -1.05 | |
| Basic EPS Qtr | -2.73 | -0.61 | -3.59 | 0.15 | -4.20 | 0.10 | -1.76 | 0.14 | -1.46 | 1.35 | -2.09 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total Revenue Annual | 33.26 | 29.82 | 29.01 | 24.68 | 26.95 | |
| Operating Expenses Annual Cr | 32.45 | 28.82 | 27.49 | 21.92 | 26.29 | |
| Operating Profit Annual | -1.27 | -1.10 | -0.45 | -0.57 | -0.81 | |
| Operating Profit Margin Annual % | -3.83 | -3.67 | -1.54 | -2.32 | -3.01 | |
| Total Expenses Annual Cr | 36.63 | 32.86 | 31.32 | 26.25 | 31.12 | |
| EBIDT Annual Cr | 0.80 | 1.00 | 1.52 | 2.76 | 0.65 | |
| EBIDT Annual margin % | 2.41 | 3.34 | 5.22 | 11.19 | 2.42 | |
| Depreciation | 2.59 | 2.54 | 2.49 | 2.99 | 3.47 | |
| PAT Before ExtraOrdinary Items Annual Cr | -3.42 | -2.88 | -2.31 | -2.11 | -4.17 | |
| Net Profit Annual | -3.42 | -2.88 | -2.31 | -2.11 | -4.17 | |
| Basic EPS Annual | -6.78 | -5.72 | -4.58 | -4.18 | -8.28 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total ShareHolders Funds Annual | 23.99 | 27.52 | 30.40 | 32.77 | 35.25 | |
| Minority Interest Liability Annual Cr | - | - | - | - | - | |
| Total Non Current Liabilities Annual Cr | 3.90 | 4.06 | 3.57 | 2.98 | 1.24 | |
| Total Current Liabilities Annual Cr | 20.51 | 17.58 | 19.92 | 21.11 | 20.20 | |
| Total Capital Plus Liabilities Annual Cr | 48.39 | 49.15 | 53.89 | 56.86 | 56.68 | |
| Fixed Assets Annual | 19.68 | 21.11 | 24.56 | 23.51 | 24.83 | |
| Total Non Current Assets Annual | 34.14 | 35.72 | 39.83 | 38.38 | 30.04 | |
| Total Current Assets Annual | 14.26 | 13.43 | 14.06 | 18.48 | 26.64 | |
| Total Assets Annual | 48.39 | 49.15 | 53.89 | 56.86 | 56.68 | |
| Contingent Liabilities plus Commitments Annual Cr | - | 19.37 | 21.96 | 21.59 | 19.82 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Cash from Operating Activity Annual | 1.36 | -1.14 | 2.33 | 2.11 | 6.11 | |
| Cash from Investing Activity Annual | 0.37 | 2.40 | -0.83 | -11.52 | -5.66 | |
| Cash from Financing Annual Activity | -1.74 | -2.03 | -1.50 | 0.61 | 3.31 | |
| Net Cash Flow Annual | - | -0.78 | -0.00 | -8.80 | 3.76 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Book Value Per Share Annual | 47.59 | 54.59 | 60.32 | 65.01 | 69.93 | |
| ROE Annual % | -14.24 | -10.47 | -7.59 | -6.43 | -11.83 | |
| ROCE Annual % | -6.39 | -4.88 | -2.86 | -0.64 | -7.73 | |
| Total Debt to Total Equity Annual | 0.46 | 0.41 | 0.39 | 0.35 | 0.28 | |
| EBDIT Annual Margin % | 2.57 | 3.58 | 5.60 | 12.94 | 2.55 |
| Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Graph |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Qtr Revenue cr | 22.06 | 24.38 | 20.71 | 22.61 | 20.19 | 19.09 | 18.94 | 18.18 | 17.73 | 19.92 | 18.85 | |
| Operating Expenses Qtr | 21.55 | 24.52 | 20.70 | 20.90 | 20.35 | 19.18 | 17.02 | 15.23 | 15.93 | 17.90 | 18.05 | |
| Operating Profit Qtr | 0.01 | -0.48 | -0.30 | 1.36 | -0.39 | -0.07 | 1.54 | 2.61 | 1.54 | 1.65 | 0.48 | |
| EBIDT Qtr Cr | 0.50 | -0.14 | 0.01 | 1.71 | -0.16 | -0.10 | 1.91 | 2.95 | 1.80 | 2.03 | 0.80 | |
| Depreciation Qtr | 0.72 | 0.73 | 0.73 | 0.72 | 1.63 | 0.40 | 0.39 | 0.42 | 0.67 | 0.67 | 0.68 | |
| Net Profit Qtr | -0.91 | -1.25 | -1.17 | 0.52 | -1.92 | -1.03 | 0.85 | 1.94 | 0.65 | 0.82 | -0.19 | |
| Basic EPS Qtr | -1.81 | -2.48 | -2.32 | 1.04 | -3.80 | -2.05 | 1.68 | 3.84 | 1.29 | 1.63 | -0.67 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total Revenue Annual | 89.76 | 76.40 | 72.09 | 59.30 | 59.03 | |
| Operating Expenses Annual Cr | 87.67 | 71.79 | 66.09 | 54.96 | 56.40 | |
| Operating Profit Annual | 0.58 | 3.69 | 4.85 | 1.92 | 2.06 | |
| Operating Profit Margin Annual % | 0.65 | 4.82 | 6.72 | 3.24 | 3.49 | |
| Total Expenses Annual Cr | 92.48 | 76.29 | 70.24 | 60.13 | 61.48 | |
| EBIDT Annual Cr | 2.08 | 4.61 | 6.00 | 4.35 | 2.63 | |
| EBIDT Annual margin % | 2.32 | 6.03 | 8.33 | 7.33 | 4.46 | |
| Depreciation | 2.90 | 2.83 | 2.67 | 3.14 | 3.62 | |
| PAT Before ExtraOrdinary Items Annual Cr | -2.92 | 0.08 | 1.85 | -1.37 | -2.45 | |
| Net Profit Annual | -2.81 | -0.17 | 1.27 | -0.91 | -1.84 | |
| Basic EPS Annual | -5.58 | -0.33 | 2.53 | -1.80 | -3.65 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total ShareHolders Funds Annual | 59.77 | 62.69 | 63.10 | 62.65 | 59.25 | |
| Minority Interest Liability Annual Cr | 4.43 | 4.60 | 4.32 | 3.65 | 0.00 | |
| Total Non Current Liabilities Annual Cr | 4.07 | 3.70 | 3.10 | 2.40 | 1.62 | |
| Total Current Liabilities Annual Cr | 46.23 | 41.27 | 39.64 | 38.12 | 41.38 | |
| Total Capital Plus Liabilities Annual Cr | 114.50 | 112.27 | 110.16 | 106.82 | 102.25 | |
| Fixed Assets Annual | 22.12 | 22.98 | 26.06 | 24.98 | 26.33 | |
| Total Non Current Assets Annual | 27.02 | 28.73 | 34.62 | 32.82 | 29.49 | |
| Total Current Assets Annual | 87.48 | 83.53 | 75.53 | 74.00 | 72.76 | |
| Total Assets Annual | 114.50 | 112.27 | 110.16 | 106.82 | 102.25 | |
| Contingent Liabilities plus Commitments Annual Cr | - | 19.37 | 21.96 | 19.66 | 19.82 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Cash from Operating Activity Annual | 4.22 | -2.77 | 5.07 | -3.66 | 3.27 | |
| Cash from Investing Activity Annual | -1.71 | 1.43 | -3.52 | -6.26 | -3.73 | |
| Cash from Financing Annual Activity | -1.64 | -2.19 | -1.66 | 2.77 | 2.94 | |
| Net Cash Flow Annual | - | -3.53 | -0.12 | -7.15 | 2.48 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Book Value Per Share Annual | 127.37 | 133.51 | 133.75 | 131.54 | 117.55 | |
| ROE Annual % | -4.70 | -0.26 | 2.01 | -1.44 | -3.10 | |
| ROCE Annual % | -1.19 | 2.50 | 4.72 | 1.75 | -1.62 | |
| Total Debt to Total Equity Annual | 0.19 | 0.18 | 0.19 | 0.18 | 0.26 | |
| EBDIT Annual Margin % | 2.36 | 6.10 | 8.46 | 7.64 | 4.50 |
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|---|---|---|---|
| POLUS GLOBAL FUND | 1.29 | 74203283 | - | - |
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|---|---|---|---|
| KRISHNA GOPAL GUPTA | 17.9 | 74203274 | 0 | 0 |
| VIKRAM GUPTA | 8.39 | 74203275 | 0 | 0 |
| GAURAV GUPTA | 8.09 | 74203276 | 0 | 0 |
| VEENA GUPTA | 5.97 | 74203277 | 0 | 0 |
| KRISHNAGOPAL GUPTA AND SONS | 5.77 | 74203278 | 0 | 0 |
| SHEFALI CHAWLA | 4.81 | 74203279 | 0 | 0 |
| Name | Holding Percent | Holding Id |
|---|---|---|
| POLUS GLOBAL FUND | 1.29 | 74203283 |
| Name | Holding Percent | Holding Id |
|---|---|---|
| KRISHNA MURARI GUPTA | 6.49 | 74203293 |
| BRIJENDRA KUMAR GUPTA | 4.86 | 74203294 |
| USHA GUPTA | 1.68 | 74203295 |
| LALIT KUMAR GUPTA | 1.4 | 74203296 |
| JYOTIVARDHAN JAIPURIA | 1.32 | 74203297 |
| Overseas Corporate Bodies | 3.97 | 74203285 |
| SOMO VISION CO. LTD. | 3.97 | 74203286 |
| HUF | 1.47 | 74203287 |
| DHWAJA COMMODITY SERVICES PRIVATE LIMITED | 1.43 | 74203290 |
| Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| Sep 21, 2010 | 1.2 | FINAL | - | Equity Share |
| Ex-Date | Split Ratio | Record Date |
|---|
| Ex-Date | Purpose | Notes |
|---|---|---|
| May 30, 2024 | Audited Results | - |
| Feb 14, 2024 | Quarterly Results | - |
| Nov 14, 2023 | Quarterly Results | - |
| Aug 11, 2023 | Quarterly Results | - |
| May 30, 2023 | Audited Results | - |
| Feb 14, 2023 | Quarterly Results | - |
| Aug 12, 2022 | Quarterly Results | - |
| May 30, 2022 | Audited Results | - |
| Feb 12, 2022 | Quarterly Results | - |
| Nov 11, 2021 | Quarterly Results | - |
| Aug 13, 2021 | Quarterly Results | - |
| Jun 10, 2021 | Audited Results | - |
| Feb 10, 2021 | Quarterly Results | - |
| Nov 12, 2020 | Quarterly Results | - |
| Aug 19, 2020 | Quarterly Results | (Revised) |
| Aug 13, 2020 | Quarterly Results | - |
| Jul 07, 2020 | Audited Results | - |
| Jun 29, 2020 | Audited Results | - |
| Mar 23, 2020 | Independent Director Meeting | - |
| Feb 13, 2020 | Quarterly Results | - |
| Jan 22, 2020 | Others | Inter alia, to consider and approve the allotment of Equity shares, pursuant to exercise of option attached to Equity Convertible Warrants allotted by the Company on July 27, 2018. |
| Dec 13, 2019 | Issue Of Warrants | - |
| Nov 13, 2019 | Quarterly Results | - |
| Aug 14, 2019 | Quarterly Results | - |
| May 30, 2019 | Audited Results | - |
| Mar 25, 2019 | Independent Director Meeting | - |
| Feb 14, 2019 | Quarterly Results | - |
| Nov 10, 2018 | Quarterly Results | - |
| Aug 14, 2018 | Quarterly Results | - |
| May 30, 2018 | Audited Results | - |
| May 10, 2018 | Others | - |
| Apr 04, 2018 | Others | - |
| Mar 27, 2018 | Others | 1. Reviewed the performance of Non-Independent Directors & the Board as a whole. 2. Reviewed the performance of the Chairperson of the Company, taking into account the views of Non-Executive Dire |
| Feb 08, 2018 | Quarterly Results | - |
| Dec 11, 2017 | Quarterly Results | - |
| Aug 10, 2017 | Quarterly Results & Others | - |
| May 29, 2017 | Audited Results | - |
| Feb 13, 2017 | Quarterly Results | - |
| Nov 10, 2016 | Quarterly Results | - |
| Aug 10, 2016 | Quarterly Results | - |
| May 30, 2016 | Audited Results & Dividend | - |
| Mar 30, 2016 | Others | Re-appointed Ms. Girija G. Nagvekar, Practising Company Secretary, as a Secretarial Auditor of the Company for the financial year 2015-16. |
| Feb 08, 2016 | Quarterly Results | - |
| Nov 07, 2015 | Quarterly Results | - |
| Aug 12, 2015 | Quarterly Results | It took note that the Company's Wholly Owned step down Subsidiary, GKB Ophthalmics Products FZE, Sharjah has acquired Lensco, The Lens Company, USA, from GKB Vision Ltd for a consideration of US$ 1. |
| May 30, 2015 | Audited Results & Dividend | Decided to sell the entire investment of 36.47% of equity share capital of GKB Vision Limited to prospective buyer Essilor India Private Limited for a total consideration of Rs. 22.91 crores. |
| Mar 31, 2015 | Others | 1. Appoint a Woman Director. 2. To re-appoint Mr. K. G. Gupta as Managing Director. 3. Appoint a Secretarial Auditor for financial year 2014-15. 4. Designate Key Managerial Personnel (KMP). |
| Feb 14, 2015 | Quarterly Results | - |
| Nov 13, 2014 | Quarterly Results | - |
| Aug 13, 2014 | Quarterly Results | - |
| Jul 05, 2014 | Others | 1. To appoint a Scrutinizer, approve the Calendar of events and to enter into agreement for e-voting for Postal Ballot.2. To delist from Madras Stock Exchange. |
| May 30, 2014 | Audited Results & Dividend | - |
| Feb 08, 2014 | Quarterly Results | - |
| Nov 14, 2013 | Quarterly Results | - |
| Aug 13, 2013 | Quarterly Results | - |
| May 28, 2013 | Audited Results & Dividend | (Revised) |
| Feb 14, 2013 | Quarterly Results | - |
| Nov 14, 2012 | Quarterly Results | - |
| Aug 13, 2012 | Quarterly Results | - |
| May 30, 2012 | Audited Results & Dividend | - |
| Feb 13, 2012 | Quarterly Results | - |
| Nov 14, 2011 | Quarterly Results | - |
| Aug 29, 2011 | Audited Results & Dividend | - |
| Aug 13, 2011 | Quarterly Results | - |
| May 15, 2011 | Quarterly Results | - |
| Feb 11, 2011 | Quarterly Results | - |
| Oct 30, 2010 | Quarterly Results | - |
| Aug 31, 2010 | Audited Results, Dividend & Others | To delist from Regional Stock Exchange, The Pune Stock Exchange Ltd. and also from The Ahmedabad Stock Exchange Ltd. and Calcutta Stock Exchange Ltd. |
| Jul 31, 2010 | Quarterly Results | - |
| Ex-Date | Bonus Ratio | Record Date |
|---|
28 Jun 2024
GKB OPHTHALMICS LTD. - 533212 - Closure of Trading Window
Dear Sir, Pursuant to SEBI( Prohibition of Insider Trading) Regulation 2015, as amended from time to time, the "Trading Window" for dealing /trading in the shares of the Company shall remain closed from July 01, 2024, till the completion of 48 hours after the declaration of the financial results of the Company \, for the first quarter ended June 30, 2024. Accordingly, all the Promoters, Directors and Designated Persons of the Company and their immediate relatives are being intimated to not to enter into any transaction involving trading in shares of the Company, during the period of closure of Trading Window. Further the date of Board meeting at which the said results will be considered , shall be intimated in due course of time. Kindly take the information on record.
27 Jun 2024
GKB OPHTHALMICS LTD. - 533212 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Dear Sir, Pursuant to Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, we wish to inform you that our Registrar and Transfer Agent viz. Link Intime India Private Limited vide email dated June 27, 2024 has informed us regarding the loss of share certificate and request for issue of duplicate share certificate to Mr. Dilnavaz Shroff,shareholder of the Company. Our Registrar and Share Transfer Agent has noted pertaining to stop Transfer in its database. The copy of email received from link Intime India Private limited, Registrar & Share Transfer Agent , is enclosed herewith Kindly take the information on record.
20 Jun 2024
GKB OPHTHALMICS LTD. - 533212 - Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015
Dear Sir, Pursuant to provision of Regulation 7(2) read with Regulation 6(2) of SEBI (Prohibition of Insider Trading) Regulation, 2015, intimation be and hereby given that Mr. Cedric Lobo, Director of the Company ,has purchased 400 equity shares aggregating to Rs. 38,424/- on 19.06.2024 of the Company ,on market. Copy of disclosure required under Regulation 7(1) (a) read with Regulation 6(2) of SEBI (Initial disclosure to the company) Regulation ,2015, received from Mr. Cedric Lobo, is enclosed herewith. Please acknowledge and take the same on record,
20 Jun 2024
GKB OPHTHALMICS LTD. - 533212 - Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015
Dear sir, Pursuant to provision of Regulation 7(2) read with Regulation 6(2) of SEBI(Prohibition of Insider Trading) Regulation, 2015, intimation be and is hereby given that Mr. Gurudas Sawant Chief Financial Officer(KMP) of the Company, has purchased 425 equity shares aggregating to Rs. 40,336/- on 19.06.2024,of the Company,on market. Copy of disclosure required under Regulation 7(2) read with Regulation 6(2) of SEBI (Prohibition of Insider Trading) Regulations,2015, is enclosed herewith. Copy of disclosure received from Mr. Gurudas Sawant, is also enclosed herewith. Please acknowledge and take the same on record
03 Jun 2024
GKB OPHTHALMICS LTD. - 533212 - Extract Of Statement Of Audited Standalone And Consolidated Financial Results For The Year Ended March 31, 2024.
Dear Sir, Please find attached copies of newspaper cuttings of the extract of Statement of audited Standalone and Consolidated Financial Results for the year ended March 31, 2024, published in The Financial Express(Mumbai Edition) and on Pudhari (Marathi) dated June 01, 2024. Please acknowledge receipt.
30 May 2024
GKB OPHTHALMICS LTD. - 533212 - GKB- Submission Of Consolidated Related Party Transactions For The Half Year Ended March 31, 2024
Dear Sir, Enclosed please find the Consolidated Related Party Transactions for the half year ended March 31, 2024. Kindly take the information on record.
30 May 2024
GKB OPHTHALMICS LTD. - 533212 - Statement Of Deviation(S) And Variation(S) Under Regulation 32 Of SEBI ( Listing Obligations And Disclosure Requirements ) Regulations, 2015 - March 31, 2024
Dear Sir, Enclosed please find the Statement of Deviation(s) and Variation(s) under Regulation 32 of SEBI ( Listing Obligations and Disclosure Requirements) Regulations, 2015, for the quarter ended March 31, 2024. Kindly take the above information on record.
30 May 2024
GKB OPHTHALMICS LTD. - 533212 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Dear Sir, Attached please find the Annual Secretarial Compliance Report for the year ended March 31, 2024. Kindly take the above information on record.
30 May 2024
GKB OPHTHALMICS LTD. - 533212 - GKB - Audited Standalone And Consolidated Financials For The Quarter And Year Ended March 31, 2024
Dear Sir, Enclosed Please find the Audited Standalone and Consolidated Financials for the quarter and year ended March 31, 2024. Kindly take the information on record.
30 May 2024
GKB OPHTHALMICS LTD. - 533212 - Board Meeting Outcome for Outcome Of Board Meeting Of GKB Ophthalmics Limited Held On May 30, 2024.
The meeting of the Board of Directors of the Company was held on May 30, 2024, which approved and took on record the Audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended March 31, 2024. Pursuant to Regulation 33 (3) (d) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosed please find the following: 1. Standalone Financial Results for the quarter and year ended March 31, 2024, together with Auditors'' Report. 2. Consolidated Financial Results for the quarter and year ended March 31, 2024, together with Auditors'' Report. 3. A declaration from CFO with respect to Audit Report with unmodified opinion for the financial year ended March 31, 2024, in terms of SEBI Circular no. CIR/ CFD/CMD/56/2016 dated May 27, 2016. The above Audited Financial Results and Auditors'' Reports'' are available on the Company''s website www.gkb.net and on the BSE website www.bseindia.com
